---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-048673"
form_type: "8-K"
ticker: "BLFS"
cik: "0000834365"
company_name: "BIOLIFE SOLUTIONS INC"
filed_at: "2024-11-20T23:59:59+00:00"
generated_at: "2026-05-29T22:15:49.883297+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# BioLife Solutions sells CBS unit to Standex for $6.1M, records $2M in stock comp and $1.5M debt repayment

## Summary
- Sold Custom Biogenic Systems (CBS) to Standex International for ~$6.1M; transaction closed Nov 14, 2024.
- Incurred $2.0M compensation expense from accelerated share vesting for CBS employees; repaid ~$1.5M of CBS debt.
- CBS results classified as discontinued operations; pro forma shows revenue reduction of ~$10.2M for 9mo 2024 and ~$13.6M for FY2023.
- Pro forma combined with prior SciSafe sale yields continuing ops net income of $6.9M for 9mo 2024 vs historical net loss $32.6M.
- Entered transition services agreement with CBS post-closing; two-year non-compete covenant.

## SEC filing metadata
- accession: 0001628280-24-048673
- form_type: 8-K
- ticker: BLFS
- cik: 0000834365
- company_name: BIOLIFE SOLUTIONS INC
- filed_at: 2024-11-20T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 2.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/834365/000162828024048673/0001628280-24-048673-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/834365/000162828024048673/blfs-20241114.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-048673
- JSON: https://secwatch.observer/filing/0001628280-24-048673.json
- Plain text: https://secwatch.observer/filing/0001628280-24-048673.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.